BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML

Bibliographic Details
Main Authors: Ossenkoppele, G, Vyas, P
Format: Journal article
Language:English
Published: American Society of Clinical Oncology 2020
_version_ 1797071624946581504
author Ossenkoppele, G
Vyas, P
author_facet Ossenkoppele, G
Vyas, P
author_sort Ossenkoppele, G
collection OXFORD
description
first_indexed 2024-03-06T22:56:03Z
format Journal article
id oxford-uuid:606912bb-1074-4283-8d36-38ef9b1cc61e
institution University of Oxford
language English
last_indexed 2024-03-06T22:56:03Z
publishDate 2020
publisher American Society of Clinical Oncology
record_format dspace
spelling oxford-uuid:606912bb-1074-4283-8d36-38ef9b1cc61e2022-03-26T17:53:18ZBCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AMLJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:606912bb-1074-4283-8d36-38ef9b1cc61eEnglishSymplectic ElementsAmerican Society of Clinical Oncology2020Ossenkoppele, GVyas, P
spellingShingle Ossenkoppele, G
Vyas, P
BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML
title BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML
title_full BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML
title_fullStr BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML
title_full_unstemmed BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML
title_short BCL-2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia: shifting from the unfit to the fit patient with AML
title_sort bcl 2 inhibitor and conventional chemotherapy combinations for acute myeloid leukemia shifting from the unfit to the fit patient with aml
work_keys_str_mv AT ossenkoppeleg bcl2inhibitorandconventionalchemotherapycombinationsforacutemyeloidleukemiashiftingfromtheunfittothefitpatientwithaml
AT vyasp bcl2inhibitorandconventionalchemotherapycombinationsforacutemyeloidleukemiashiftingfromtheunfittothefitpatientwithaml